At 2.7% CAGR, the Middle East & Africa Cerebrospinal Fluid Management Market is projected to be worth US$ 95.51 million by 2030, says Business Market Insights

According to Business Market Insights’ research, the Middle East & Africa cerebrospinal fluid management market was valued at US$ 77.06 million in 2022 and is expected to reach US$ 95.51 million by 2030, registering a CAGR of 2.7% from 2022 to 2030. Increasing cases of cerebrospinal fluid leak is among the critical factors attributed to the Middle East & Africa cerebrospinal fluid management market expansion.             

According to the Journal of Neurosurgery, more than 69 million people globally are estimated to suffer from traumatic brain injuries annually. Brain and spinal injuries are the most common causes of cerebrospinal fluid (CSF) leaks in adults, necessitating CSF management. High blood pressure, majorly caused due to a shift in lifestyle and unhealthy habits, is another notable cause of CSF leaks among adults and elderlies. Similarly, high blood pressure is common in elderly people, which ultimately leads to an increasing risk of idiopathic intracranial hypertension (IIH). Thus, the growing geriatric population can be associated with the growth of the cerebrospinal fluid management market. The incidence of hydrocephalus is growing significantly across the world. The occurrence of hydrocephalus is highest in the geriatric population; notably, it is higher in the pediatric population compared to adults. According to an article published by the National Library of Medicine (NLM), the global prevalence of hydrocephalus is ~85 per 100,000 individuals. Per the same source, the prevalence rate in the pediatric population is ~88 per 100,000 whereas the rate is ~11 per 100,000 in adults and ~175 per 100,000 in the geriatric population. Further, the incidence rate of hydrocephalus in low- and medium-income countries is ~123 per 100,000 births whereas the rate in high-income countries is 79 per 100,000 births. The CSF shunts and drainage systems are the treatment options suitable for hydrocephalus cases diagnosed in people from all age groups. Hence, an increase in CSF leak cases boosts the growth of the CSF management market.

On the contrary, risk of failure and malfunctioning hampers on the growth of Middle East & Africa cerebrospinal fluid management market. 

Based on product, the Middle East & Africa cerebrospinal fluid management market is bifurcated into CSF shunts and CSF drainage systems. The CSF shunts segment held 82.2% share of Middle East & Africa cerebrospinal fluid management market in 2022, amassing US$ 63.37 million. It is projected to garner US$ 79.68 million by 2030 to expand at 2.9% CAGR during 2022–2030.

Based on end user, the Middle East & Africa cerebrospinal fluid management market is segmented into hospitals, clinics, ambulatory surgical centers, and others. The hospitals segment held 47.9% share of Middle East & Africa cerebrospinal fluid management market in 2022, amassing US$ 36.95 million. It is projected to garner US$ 46.92 million by 2030 to expand at 3.0% CAGR during 2022–2030.

Based on country, the Middle East & Africa cerebrospinal fluid management market has been categorized into Saudi Arabia, South Africa, UAE, and the Rest of Middle East & Africa. Our regional analysis states that Saudi Arabia captured 33.7% share of Middle East & Africa cerebrospinal fluid management market in 2022. It was assessed at US$ 25.97 million in 2022 and is likely to hit US$ 32.64 million by 2030, exhibiting a CAGR of 2.9% during 2022–2030.            

Key players operating in the Middle East & Africa cerebrospinal fluid management market are Argi Group Health Services Ltd Sti, B. Braun SE, Integra LifeSciences Holdings Corp, Medtronic Plc, and Spiegelberg GmbH & Co KG, among others.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com